Characteristics and Outcomes of Patients Treated With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (The Mayo Clinic Experience)
Autor: | Oren, Ohad, Kludtke, Erica L., Kopecky, Stephen L. |
---|---|
Zdroj: | In The American Journal of Cardiology 1 December 2019 124(11):1669-1673 |
Databáze: | ScienceDirect |
Externí odkaz: |